MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT

Abstract

Introduction. Familial hypertrophic cardiomyopathy (HCM) occurs as an autosomal dominant mendelian inherited disease in about 50 percent cases. abstractive and nonobstractive were two forms of HCM. The most common treatment modalities include drug therapy, mitral valve replacement, installation of dual chamber DD pacemaker and surgical excision of a portion of the hypertrophied septum. Methods. One of the newest methods used in recent years for the treatment of HCM unresponsive to common medical procedures is to inject alcohol into septal artery (septal ablation). We used a modified version of this procedure which consisted of using transesophageal echocardiography evaluation of mitral regurgitation and the diagnosis of septal artery during alcohol injection in a HCM patient. Results. The short term (immediately after procedure) and the long term (after 3 months) evaluation indicates complete improvement of clinical symptoms in the patient. Discussion. Considering the clinical improvement of symptoms, increased tolerance for activity and reduced gradient in LV outflow tract, this procedure is an effective method for the treatment of HCM resistant to common medical therapy.